Quest Diagnostics, headquartered in Secaucus, New Jersey, employs 40,000 staff and provides diagnostic testing services to physicians, hospitals, and patients through a nationwide network. The company utilizes AI and digital solutions to enhance laboratory functions and support biopharmaceutical companies.
Mark E Delaney sold 874 shares of DGX on 12 May at $175.72 per share, worth a total of $154K. They now own 8,372 DGX shares, or a 9% holding decrease.
📡️ Health Care
Insider Trades
More Signals
Feature in Progress
This section is under development. Check back soon for updates!
